SCR-LIP-000230 · Claim · machine-readable JSON →
This review reports that lipedema develops or worsens during hormonal-change windows (puberty, pregnancy, menopause, oral contraceptives), with ~20% of cases identified at menopause and ~67% of patients reporting symptom exacerbation at its onset, and proposes an estrogen-receptor imbalance (decreased ERalpha/increased ERbeta) in affected adipose tissue as a central mechanism.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema: From Women’s Hormonal Changes to Nutritional Intervention — Tomada (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“lipedema se desenvolve ou piora em janelas de mudança hormonal — cerca de 20% dos casos são identificados na menopausa e aproximadamente 67% das pacientes relatam exacerbação de sintomas ao seu início; estrogênio favorece deposição de gordura gluteofemoral”
Narrative review summarizing hormonal etiopathogenesis of lipedema, including estrogen, estrogen receptor ratios, and reproductive-life hormonal triggers; directly addresses the hormonal influence on onset, though heredity is not strongly d [grade capped low->very_low per curated Oxford N6]
Context (PECO)
Answers these questions
- Do hormones and heredity influence the onset of lipedema? consistent
- Do hormonal factors (puberty, pregnancy, menopause, estrogen) trigger or influence lipedema onset? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000012